Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

CCCA may be caused by both hair traction and an immune response.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Increased Stat3 activity reduces hair follicle stem cells and boosts other stem/progenitor cells.

PTCH gene mutations contribute to basal cell carcinoma development.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Loss of Dnmt3a and Dnmt3b increases aggressive skin tumors by affecting PPAR-γ.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Telocytes in the scalp may help with skin regeneration and maintenance.

Trichohyalin in hair can trigger immune attacks in alopecia areata.

A new 3D breast tumor model helps test drug effects more accurately than traditional methods.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.